{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:27:42Z","timestamp":1790375262263,"version":"4.1.0"},"reference-count":195,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Health Technology R&amp;D Project funded by the Korean Ministry of Health &amp; Welfare","award":["HR22C1363"],"award-info":[{"award-number":["HR22C1363"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fibrous dysplasia (FD) is a rare, non-hereditary skeletal disorder characterized by its chronic course of non-neoplastic fibrous tissue buildup in place of healthy bone. A myriad of factors have been associated with its onset and progression. Perturbation of cell\u2013cell signaling networks and response outputs leading to disrupted building blocks, incoherent multi-level organization, and loss of rigid structural motifs in mineralized tissues are factors that have been identified to participate in FD induction. In more recent years, novel insights into the unique biology of FD are transforming our understandings of its pathology, natural discourse of the disease, and treatment prospects. Herein, we built upon existing knowledge with recent findings to review clinical, etiologic, and histological features of FD and discussed known and potential mechanisms underlying FD manifestations. Subsequently, we ended on a note of optimism by highlighting emerging therapeutic approaches aimed at either halting or ameliorating disease progression.<\/jats:p>","DOI":"10.3390\/ijms242115591","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T02:40:07Z","timestamp":1698288007000},"page":"15591","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A Rare Skeletal Disorder, Fibrous Dysplasia: A Review of Its Pathogenesis and Therapeutic Prospects"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-5249","authenticated-orcid":false,"given":"Ha-Young","family":"Kim","sequence":"first","affiliation":[{"name":"Interdisciplinary Program in Bioengineering, Seoul National University, Seoul 08826, Republic of Korea"},{"name":"Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hee","family":"Shim","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea"},{"name":"Department of Research Administration Team, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Yeong","family":"Heo","sequence":"additional","affiliation":[{"name":"Interdisciplinary Program in Bioengineering, Seoul National University, Seoul 08826, Republic of Korea"},{"name":"Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"},{"name":"Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000058106","article-title":"Fibrous Dysplasia","volume":"57","author":"Schoenau","year":"2002","journal-title":"Horm. Res. Paediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/archdischild-2013-304490","article-title":"Fibrous Dysplasia Causing Safeguarding Concerns","volume":"98","author":"Pai","year":"2013","journal-title":"Arch. Dis. Child."},{"key":"ref_3","first-page":"20","article-title":"Clinical Presentation and Outcome of Fibrous Dysplasia in Patients Attending Sahiwal Teaching Hospital, Punjab","volume":"1","author":"Lail","year":"2022","journal-title":"J. Univ. Coll. Med. Dent."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s13244-018-0666-6","article-title":"Fibrous Dysplasia for Radiologists: Beyond Ground Glass Bone Matrix","volume":"9","author":"Kushchayeva","year":"2018","journal-title":"Insights Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright Syndrome","volume":"3","author":"Dumitrescu","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00586-008-0860-1","article-title":"Scoliosis and Spine Involvement in Fibrous Dysplasia of Bone","volume":"18","author":"Mancini","year":"2009","journal-title":"Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1750-1172-7-S1-S2","article-title":"Clinical Guidelines for the Management of Craniofacial Fibrous Dysplasia","volume":"7","author":"Lee","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10143-019-01089-1","article-title":"Malignant Transformation of Craniofacial Fibrous Dysplasia: A Systematic Review of Overall Survival","volume":"43","author":"Li","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1750-1172-7-S1-S1","article-title":"The Surgical Management of Fibrous Dysplasia of Bone","volume":"7","author":"Stanton","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-016-0317-0","article-title":"Fibrous Dysplasia\/McCune-Albright Syndrome: Clinical and Translational Perspectives","volume":"14","author":"Robinson","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116270","DOI":"10.1016\/j.bone.2021.116270","article-title":"Fibrous Dysplasia Animal Models: A Systematic Review","volume":"155","author":"Hopkins","year":"2022","journal-title":"Bone"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/jbmr.2267","article-title":"Constitutive Expression of Gs\u03b1 R201C in Mice Produces a Heritable, Direct Replica of Human Fibrous Dysplasia Bone Pathology and Demonstrates Its Natural History: Mouse Model of Human Fibrous Dysplasia","volume":"29","author":"Saggio","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11282-012-0080-6","article-title":"Successive Generations with Inherited Craniofacial Fibrous Dysplasia","volume":"28","author":"Charoenlarp","year":"2012","journal-title":"Oral Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/jbmr.080609","article-title":"Age-Dependent Demise of GNAS -Mutated Skeletal Stem Cells and \u201cNormalization\u201d of Fibrous Dysplasia of Bone","volume":"23","author":"Kuznetsov","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00005792-199607000-00001","article-title":"Clinical Implications of Genetic Defects in G Proteins: The Molecular Basis of McCune-Albright Syndrome and Albright Hereditary Osteodystrophy","volume":"75","author":"Ringel","year":"1996","journal-title":"Medicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1359\/jbmr.1999.14.3.336","article-title":"Diseases of Bone and the Stromal Cell Lineage","volume":"14","author":"Bianco","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI2361","article-title":"Reproduction of Human Fibrous Dysplasia of Bone in Immunocompromised Mice by Transplanted Mosaics of Normal and Gsalpha-Mutated Skeletal Progenitor Cells","volume":"101","author":"Bianco","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jop.12797","article-title":"Fibrous Dysplasia of the Jaws: Integrating Molecular Pathogenesis with Clinical, Radiological, and Histopathological Features","volume":"48","author":"Pereira","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/modpathol.2012.223","article-title":"Diagnostic Value of Investigating GNAS Mutations in Fibro-Osseous Lesions: A Retrospective Study of 91 Cases of Fibrous Dysplasia and 40 Other Fibro-Osseous Lesions","volume":"26","author":"Collin","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmoldx.2010.10.003","article-title":"Quantitative Analysis of Activating Alpha Subunit of the G Protein (Gs\u03b1) Mutation by Pyrosequencing in Fibrous Dysplasia and Other Bone Lesions","volume":"13","author":"Liang","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1210\/jcem-68-6-1148","article-title":"Hypersecretion of Growth Hormone and Prolactin in McCune-Albright Syndrome","volume":"68","author":"Cuttler","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/365652a0","article-title":"A Constitutively Activating Mutation of the Luteinizing Hormone Receptor in Familial Male Precocious Puberty","volume":"365","author":"Shenker","year":"1993","journal-title":"Nature"},{"key":"ref_23","first-page":"803","article-title":"An Unusual Presentation of McCune-Albright Syndrome Confirmed by an Activating Mutation of the Gs Alpha-Subunit from a Bone Lesion","volume":"78","author":"Malchoff","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0188-4409(99)00075-2","article-title":"Clinical Implications of Genetic Defects in G Proteins","volume":"30","author":"Levine","year":"1999","journal-title":"Arch. Med. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2559.2007.02676.x","article-title":"A Sensitive Mutation-Specific Screening Technique for GNAS1 Mutations in Cases of Fibrous Dysplasia: The First Report of a Codon 227 Mutation in Bone","volume":"50","author":"Idowu","year":"2007","journal-title":"Histopathology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fgene.2019.00862","article-title":"Improved Molecular Diagnosis of McCune\u2013Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR","volume":"10","author":"Elli","year":"2019","journal-title":"Front. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal Bone Anatomy and Physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1677\/JME-10-0097","article-title":"Skeletal Progenitors and the GNAS Gene: Fibrous Dysplasia of Bone Read through Stem Cells","volume":"45","author":"Riminucci","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","article-title":"The Histopathology of Fibrous Dysplasia of Bone in Patients with Activating Mutations of the Gs? Gene: Site-Specific Patterns and Recurrent Histological Hallmarks","volume":"187","author":"Riminucci","year":"1999","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Raimondo, D., Remoli, C., Astrologo, L., Burla, R., La Torre, M., Vern\u00ec, F., Tagliafico, E., Corsi, A., Del Giudice, S., and Persichetti, A. (2020). Changes in Gene Expression in Human Skeletal Stem Cells Transduced with Constitutively Active Gs\u03b1 Correlates with Hallmark Histopathological Changes Seen in Fibrous Dysplastic Bone. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227279"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1302\/0301-620X.44B2.302","article-title":"Fibrous Dysplasia of Bone","volume":"44","author":"Stewart","year":"1962","journal-title":"J. Bone Joint Surg. Br."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jbmr.3602","article-title":"Activation of RANK\/RANKL\/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated with Disease Burden","volume":"34","author":"Burke","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_33","first-page":"1587","article-title":"Fibrous Dysplasia of Bone in the McCune-Albright Syndrome: Abnormalities in Bone Formation","volume":"151","author":"Riminucci","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00388097","article-title":"Fibrous Dysplasia with Locally Aggressive Malignant Change","volume":"111","author":"Latham","year":"1992","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/jbmr.2003.18.7.1235","article-title":"Osteomalacic and Hyperparathyroid Changes in Fibrous Dysplasia of Bone: Core Biopsy Studies and Clinical Correlations","volume":"18","author":"Corsi","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.4111","article-title":"A Signature of Circulating miRNAs Associated with Fibrous Dysplasia of Bone: The mirDys Study","volume":"35","author":"Legrand","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fogelman, I., Gnanasegaran, G., and Van Der Wall, H. (2012). Radionuclide and Hybrid Bone Imaging, Springer.","DOI":"10.1007\/978-3-642-02400-9"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Donsante, S., Palmisano, B., Serafini, M., Robey, P.G., Corsi, A., and Riminucci, M. (2021). From Stem Cells to Bone-Forming Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083989"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.20958","article-title":"Regulation of Osteoblast Differentiation by Transcription Factors","volume":"99","author":"Komori","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM198307143090206","article-title":"Regulation of Bone Formation","volume":"309","author":"Raisz","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_41","first-page":"103","article-title":"Osteoblasts and Bone Formation","volume":"32","author":"Fonseca","year":"2007","journal-title":"Acta Reumatol. Port."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fphar.2020.00757","article-title":"The Bone Extracellular Matrix in Bone Formation and Regeneration","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Amarasekara, D.S., Kim, S., and Rho, J. (2021). Regulation of Osteoblast Differentiation by Cytokine Networks. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062851"},{"key":"ref_44","unstructured":"Rosen, C.J. (2009). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, John Wiley & Sons."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mpo.10334","article-title":"Biology of the Basic Multicellular Unit and the Pathophysiology of Osteoporosis","volume":"41","author":"Jilka","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_46","unstructured":"Marie, P.J., Fromigu\u00e9, O., and Modrowski, D. (2015). Bone Cancer, Elsevier."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0046-8177(99)90162-4","article-title":"A Comparative Study of Fibrous Dysplasia and Osteofibrous Dysplasia with Regard to Expressions of C-Fos and c-Jun Products and Bone Matrix Proteins: A Clinicopathologic Review and Immunohistochemical Study of c-Fos, c-Jun, Type I Collagen, Osteonectin, Osteopontin, and Osteocalcin","volume":"30","author":"Sakamoto","year":"1999","journal-title":"Hum. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/ten.teb.2019.0312","article-title":"Interrogating the Osteogenic Potential of Implant Surfaces In Vitro : A Review of Current Assays","volume":"26","author":"Avery","year":"2020","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"23976","DOI":"10.1074\/jbc.273.37.23976","article-title":"A Novel Mutation in the Switch 3 Region of Gs\u03b1 in a Patient with Albright Hereditary Osteodystrophy Impairs GDP Binding and Receptor Activation","volume":"273","author":"Warner","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_50","first-page":"1718","article-title":"A Novel Mutation Adjacent to the Switch III Domain of Gs\u03b1 in a Patient with Pseudohypoparathyroidism","volume":"11","author":"Warner","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","article-title":"Minireview: GNAS: Normal and Abnormal Functions","volume":"145","author":"Weinstein","year":"2004","journal-title":"Endocrinology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0166-2236(90)90045-C","article-title":"Regulation of Camp-Inducible Genes by Creb","volume":"13","author":"Montminy","year":"1990","journal-title":"Trends Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Shen, L., He, Y., Chen, S., He, L., and Zhang, Y. (2023). PTHrP Modulates the Proliferation and Osteogenic Differentiation of Craniofacial Fibrous Dysplasia-Derived BMSCs. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087616"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1368-8375(02)00037-4","article-title":"Fibrous Dysplasia in the Maxilla: Possible Mechanism of Bone Remodeling by Calcitonin Treatment","volume":"39","author":"Yasuoka","year":"2003","journal-title":"Oral Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101156","DOI":"10.1016\/j.bonr.2021.101156","article-title":"Nanostring Technology on Fibrous Dysplasia Bone Biopsies. A Pilot Study Suggesting Different Histology-Related Molecular Profiles","volume":"16","author":"Persichetti","year":"2022","journal-title":"Bone Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11832-007-0006-8","article-title":"Current Approach to Fibrous Dysplasia of Bone and McCune\u2013Albright Syndrome","volume":"1","author":"Leet","year":"2007","journal-title":"J. Child. Orthop."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1114656108","article-title":"Wnt\/\u03b2-Catenin Signaling Is Differentially Regulated by G\u03b1 Proteins and Contributes to Fibrous Dysplasia","volume":"108","author":"Regard","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jre.12294","article-title":"Wnt3a Signaling Induces Murine Dental Follicle Cells to Differentiate into Cementoblastic\/Osteoblastic Cells via an Osterix-Dependent Pathway","volume":"51","author":"Nemoto","year":"2016","journal-title":"J. Periodontal Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/ten.tea.2016.0387","article-title":"Effects of WNT3A and WNT16 on the Osteogenic and Adipogenic Differentiation of Perivascular Stem\/Stromal Cells","volume":"24","author":"Shen","year":"2018","journal-title":"Tissue Eng. Part A"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/jbmr.440","article-title":"High Levels of \u03b2-Catenin Signaling Reduce Osteogenic Differentiation of Stem Cells in Inflammatory Microenvironments through Inhibition of the Noncanonical Wnt Pathway","volume":"26","author":"Liu","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcb.20284","article-title":"Wnt3a Promotes Proliferation and Suppresses Osteogenic Differentiation of Adult Human Mesenchymal Stem Cells","volume":"93","author":"Boland","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.4033","article-title":"The CREB-Smad6-Runx2 Axis Contributes to the Impaired Osteogenesis Potential of Bone Marrow Stromal Cells in Fibrous Dysplasia of Bone","volume":"228","author":"Fan","year":"2012","journal-title":"J. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3724\/abbs.2023018","article-title":"Cyclic Di-Adenosine Monophosphate Regulates the Osteogenic and Adipogenic Differentiation of hPDLSCs via MAPK and NF-\u03baB Signaling","volume":"55","author":"Chen","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_64","first-page":"E428","article-title":"Expression of an Active G\u03b1s Mutant in Skeletal Stem Cells Is Sufficient and Necessary for Fibrous Dysplasia Initiation and Maintenance","volume":"115","author":"Zhao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijom.2009.12.008","article-title":"Prognosis for Craniofacial Fibrous Dysplasia after Incomplete Resection: Age and Serum Alkaline Phosphatase","volume":"39","author":"Park","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jcms.2012.12.007","article-title":"A Retrospective Study on Craniofacial Fibrous Dysplasia: Preoperative Serum Alkaline Phosphatase as a Prognostic Marker?","volume":"41","author":"Ma","year":"2013","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s13018-020-02073-y","article-title":"Increasing Serum Alkaline Phosphatase Is Associated with Bone Deformity Progression for Patients with Polyostotic Fibrous Dysplasia","volume":"15","author":"Wang","year":"2020","journal-title":"J. Orthop. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/dvdy.21187","article-title":"Runx2 Determines Bone Maturity and Turnover Rate in Postnatal Bone Development and Is Involved in Bone Loss in Estrogen Deficiency","volume":"236","author":"Maruyama","year":"2007","journal-title":"Dev. Dyn."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/sctm.18-0057","article-title":"HDAC8, A Potential Therapeutic Target, Regulates Proliferation and Differentiation of Bone Marrow Stromal Cells in Fibrous Dysplasia","volume":"8","author":"Xiao","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_70","first-page":"531","article-title":"Frequent Immunoexpression of TGF-\u03921, FGF-2 and BMP-2 in Fibroblast-like Cells in Osteofibrous Dysplasia","volume":"17","author":"Sakamoto","year":"2007","journal-title":"Oncol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 Signaling in Fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"ref_72","first-page":"77","article-title":"Immunolocalization of Bmp2\/4, Tgf\u03b2-1 and Osteonectin in Fibro-Osseous Lesions of the Jaws","volume":"11","author":"Sobral","year":"2011","journal-title":"Rev. De Cir. E Traumatol. Buco-Maxilo-Facial"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.21037\/apm-21-2509","article-title":"Predictive Markers for Severe Hypocalcemia in Dialysis Patients with Secondary Hyperparathyroidism after Near-Total Parathyroidectomy","volume":"10","author":"Zou","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/cbir.1994.1088","article-title":"Why Does Bone Matrix Contain Non-Collagenous Proteins? The Possible Roles of Osteocalcin, Osteonectin, Osteopontin and Bone Sialoprotein in Bone Mineralisation and Resorption","volume":"18","author":"Roach","year":"1994","journal-title":"Cell Biol. Int."},{"key":"ref_75","first-page":"1059","article-title":"Increased Proliferation of Osteoblastic Cells Expressing the Activating Gs Alpha Mutation in Monostotic and Polyostotic Fibrous Dysplasia","volume":"150","author":"Marie","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1746-160X-5-22","article-title":"The Nature of Fibrous Dysplasia","volume":"5","author":"Feller","year":"2009","journal-title":"Head Face Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.14.10.1648","article-title":"Osteopontin Is Synthesized by Macrophage, Smooth Muscle, and Endothelial Cells in Primary and Restenotic Human Coronary Atherosclerotic Plaques","volume":"14","author":"Garvin","year":"1994","journal-title":"Arterioscler. Thromb. J. Vasc. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/ki.1997.243","article-title":"Osteopontin Regulation in Cultured Rat Renal Epithelial Cells","volume":"51","author":"Malyankar","year":"1997","journal-title":"Kidney Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15722","DOI":"10.1038\/s41598-020-72786-x","article-title":"Osteopontin Regulates Biomimetic Calcium Phosphate Crystallization from Disordered Mineral Layers Covering Apatite Crystallites","volume":"10","author":"Nanda","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.actbio.2013.10.010","article-title":"Multifunctional Role of Osteopontin in Directing Intrafibrillar Mineralization of Collagen and Activation of Osteoclasts","volume":"10","author":"Rodriguez","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous Dysplasia\/McCune-Albright Syndrome: A Rare, Mosaic Disease of G\u03b1 s Activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_82","first-page":"e919159","article-title":"Osteopontin in Bone Metabolism and Bone Diseases","volume":"26","author":"Si","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in Fibrous Dysplasia of Bone and Its Relationship to Renal Phosphate Wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/qjmed\/hcs001","article-title":"Possible Mechanisms of Interaction between Statins and Vitamin D","volume":"105","author":"Bhattacharyya","year":"2012","journal-title":"QJM"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.30","article-title":"Action of RANKL and OPG for Osteoclastogenesis","volume":"19","author":"Kobayashi","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2016.08.010","article-title":"Fibroblast Growth Factor 23 Inhibits Osteoblastic Gene Expression and Induces Osteoprotegerin in Vascular Smooth Muscle Cells","volume":"253","author":"Nakahara","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1073\/pnas.1714313114","article-title":"Induced Gnas  R201H  Expression from the Endogenous Gnas Locus Causes Fibrous Dysplasia by up-Regulating Wnt\/\u03b2-Catenin Signaling","volume":"115","author":"Khan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"116744","DOI":"10.1016\/j.bone.2023.116744","article-title":"Clinical Value of RANKL, OPG, IL-6 and Sclerostin as Biomarkers for Fibrous Dysplasia\/McCune-Albright Syndrome","volume":"171","author":"Meier","year":"2023","journal-title":"Bone"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of Sclerostin in Bone and Cartilage and Its Potential as a Therapeutic Target in Bone Diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/01913128609015563","article-title":"Ultrastructure of Fibrous Dysplasia of Bone: A Study of Its Fibrous, Osseous, and Cartilaginous Components","volume":"10","author":"Greco","year":"1986","journal-title":"Ultrastruct. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1359\/jbmr.091036","article-title":"Transfer, Analysis and Reversion of the Fibrous Dysplasia Cellular Phenotype in Human Skeletal Progenitors","volume":"25","author":"Piersanti","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_92","unstructured":"Weinstein, L.S., and Collins, M.T. (2018). Genetics of Bone Biology and Skeletal Disease, Elsevier."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bone.2015.12.003","article-title":"Bone Marrow Fibrosis with Fibrocytic and Immunoregulatory Responses Induced by \u03b2-Catenin Activation in Osteoprogenitors","volume":"84","author":"Yu","year":"2016","journal-title":"Bone"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","article-title":"New Developments in Fibroblast and Myofibroblast Biology: Implications for Fibrosis and Scleroderma","volume":"9","author":"Abraham","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bartl, R., and Bartl, C. (2017). Bone Disorders, Springer International Publishing.","DOI":"10.1007\/978-3-319-29182-6"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/1535370215584933","article-title":"Bone Marrow-Derived Fibrocytes Contribute to Liver Fibrosis","volume":"240","author":"Xu","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0309132","article-title":"The Role of Circulating Mesenchymal Progenitor Cells (Fibrocytes) in the Pathogenesis of Pulmonary Fibrosis","volume":"86","author":"Strieter","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.bor.0000245725.94887.8d","article-title":"Nephrogenic Systemic Fibrosis (Nephrogenic Fibrosing Dermopathy)","volume":"18","author":"Galan","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biomaterials.2016.08.042","article-title":"Pro-Fibrotic Effects of PFKFB4-Mediated Glycolytic Reprogramming in Fibrous Dysplasia","volume":"107","author":"Lee","year":"2016","journal-title":"Biomaterials"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-981-13-8871-2_18","article-title":"Inflammatory Mediators and Renal Fibrosis","volume":"Volume 1165","author":"Liu","year":"2019","journal-title":"Renal Fibrosis: Mechanisms and Therapies"},{"key":"ref_101","first-page":"ZC14-17","article-title":"Evaluation of Myofibroblasts by Expression of Alpha Smooth Muscle Actin: A Marker in Fibrosis, Dysplasia and Carcinoma","volume":"8","author":"Rao","year":"2014","journal-title":"J. Clin. Diagn. Res. JCDR"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The Origin of Fibroblasts and Mechanism of Cardiac Fibrosis","volume":"225","author":"Krenning","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0344-0338(96)80092-6","article-title":"The Cellular Derivation and the Life Span of the Myofibroblast","volume":"192","author":"Gabbiani","year":"1996","journal-title":"Pathol. Res. Pract."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.humpath.2008.07.008","article-title":"Periostin, a Novel Marker of Intramembranous Ossification, Is Expressed in Fibrous Dysplasia and in c-Fos\u2013Overexpressing Bone Lesions","volume":"40","author":"Kashima","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., and Marumo, K. (2019). The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225525"},{"key":"ref_106","first-page":"8532","article-title":"Gene Expression Profiling of Craniofacial Fibrous Dysplasia Reveals ADAMTS2 Overexpression as a Potential Marker","volume":"7","author":"Zhou","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/odi.12624","article-title":"Regulation of Bone Remodeling by Vitamin K2","volume":"23","author":"Myneni","year":"2017","journal-title":"Oral Dis."},{"key":"ref_108","first-page":"954","article-title":"Fibrous Dysplasia and Central Giant Cell Granuloma: A Report of Hybrid Lesion with Its Review and Hypotheticated Pathogenesis","volume":"7","author":"Kurra","year":"2013","journal-title":"J. Clin. Diagn. Res. JCDR"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1359\/jbmr.1999.14.7.1104","article-title":"Glucocorticoids Decrease Interleukin-6 Levels and Induce Mineralization of Cultured Osteogenic Cells from Children with Fibrous Dysplasia","volume":"14","author":"Stanton","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1359\/jbmr.06s223","article-title":"Gs\u03b1 Mutations in Fibrous Dysplasia and McCune-Albright Syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_111","first-page":"1511","article-title":"Fibrous Dysplasia of Bone: The Bone Lesion Unmasked","volume":"151","author":"Singer","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","article-title":"Osteoclastogenesis in Fibrous Dysplasia of Bone: In Situ and in Vitro Analysis of IL-6 Expression","volume":"33","author":"Riminucci","year":"2003","journal-title":"Bone"},{"key":"ref_113","first-page":"253","article-title":"Prompt Clinical and Biochemical Response to Denosumab in a Young Adult Patient with Craniofacial Fibrous Dysplasia","volume":"13","author":"Rossi","year":"2016","journal-title":"Clin. Cases Miner. Bone Metab. Off. J. Ital. Soc. Osteoporos. Miner. Metab. Skelet. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., and Yu, T. (2021). Recent Advances in Osteoclast Biological Behavior. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.788680"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e4179","DOI":"10.1210\/clinem\/dgaa091","article-title":"Denosumab for Fibrous Dysplasia: Promising, but Questions Remain","volume":"105","author":"Collins","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/EJE-19-0969","article-title":"Diagnosis of Endocrine Disease: Mosaic Disorders of FGF23 Excess: Fibrous Dysplasia\/McCune-Albright Syndrome and Cutaneous Skeletal Hypophosphatemia Syndrome","volume":"182","author":"Ovejero","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"778078","DOI":"10.3389\/fimmu.2021.778078","article-title":"Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., and Mizoguchi, I. (2020). Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145169"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of Bone Remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tucker-Bartley, A., Selen, D.J., Golden, E., Van Gool, R., Ebb, D., Mannstadt, M., and Upadhyay, J. (2023). Pharmacological Interventions Targeting Pain in Fibrous Dysplasia\/McCune\u2013Albright Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032550"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","article-title":"Pathophysiology and Medical Treatment of Pain in Fibrous Dysplasia of Bone","volume":"7","author":"Chapurlat","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","article-title":"Pain in Fibrous Dysplasia of Bone: Age-Related Changes and the Anatomical Distribution of Skeletal Lesions","volume":"19","author":"Kelly","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17453674.2019.1608117","article-title":"Pain in Fibrous Dysplasia: Relationship with Anatomical and Clinical Features","volume":"90","author":"Majoor","year":"2019","journal-title":"Acta Orthop."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13023-022-02588-z","article-title":"A Multidisciplinary Care Pathway Improves Quality of Life and Reduces Pain in Patients with Fibrous Dysplasia\/McCune-Albright Syndrome: A Multicenter Prospective Observational Study","volume":"17","author":"Meier","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3171\/JNS\/2008\/109\/11\/0889","article-title":"Use of High-Dose Oral Bisphosphonate Therapy for Symptomatic Fibrous Dysplasia of the Skull: Case Report","volume":"109","author":"Chao","year":"2008","journal-title":"J. Neurosurg."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10067-008-0842-z","article-title":"Bisphosphonate Treatment in Craniofacial Fibrous Dysplasia\u2014A Case Report and Review of the Literature","volume":"27","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab Treatment for Fibrous Dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1210\/jc.2018-02543","article-title":"Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates","volume":"104","author":"Majoor","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.0000000000001382","article-title":"Ion Channels in Nociceptors: Recent Developments","volume":"84","author":"Benarroch","year":"2015","journal-title":"Neurology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5313\/wja.v3.i1.71","article-title":"Molecular Mechanism of Inflammatory Pain","volume":"3","author":"Su","year":"2014","journal-title":"World J. Anesthesiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2006.04.033","article-title":"Osteoclasts Play a Part in Pain Due to the Inflammation Adjacent to Bone","volume":"39","author":"Nagae","year":"2006","journal-title":"Bone"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","article-title":"Mechanisms of Cancer-Induced Bone Pain","volume":"23","author":"Middlemiss","year":"2011","journal-title":"Clin. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SPC.0000000000000048","article-title":"Bone Cancer Pain: From Mechanism to Therapy","volume":"8","author":"Mantyh","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","article-title":"Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve Fibers","volume":"12","author":"Bloom","year":"2011","journal-title":"J. Pain"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/SPC.0b013e328133f5e9","article-title":"Central Neuronal Mechanisms in Cancer-Induced Bone Pain","volume":"1","author":"Dickenson","year":"2007","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e2258","DOI":"10.1210\/clinem\/dgac120","article-title":"Neuropathic-like Pain in Fibrous Dysplasia\/McCune-Albright Syndrome","volume":"107","author":"Spencer","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant Bone Pain: Pathophysiology and Treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2003-030050","article-title":"Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone","volume":"88","author":"Plotkin","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/pm\/pnac090","article-title":"Intravenous Bisphosphonate Therapy as a Rescue Analgesic in Refractory Fibrous Dysplasia","volume":"23","author":"Hatcher","year":"2022","journal-title":"Pain Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"116819","DOI":"10.1016\/j.bone.2023.116819","article-title":"Denosumab Use in Bone Fibrous Dysplasia Refractory to Bisphosphonate: A Retrospective Multicentric Study","volume":"174","author":"Trojani","year":"2023","journal-title":"Bone"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"115784","DOI":"10.1016\/j.bone.2020.115784","article-title":"Bisphosphonates for the Treatment of Fibrous Dysplasia of Bone","volume":"143","author":"Chapurlat","year":"2021","journal-title":"Bone"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2014-1371","article-title":"A Randomized, Double Blind, Placebo-Controlled Trial of Alendronate Treatment for Fibrous Dysplasia of Bone","volume":"99","author":"Boyce","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","article-title":"Treatment of Fibrous Dysplasia of Bone with Intravenous Pamidronate: Long-Term Effectiveness and Evaluation of Predictors of Response to Treatment","volume":"35","author":"Chapurlat","year":"2004","journal-title":"Bone"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"582316","DOI":"10.3389\/fped.2020.582316","article-title":"Response to Zoledronic Acid Infusion in Children with Fibrous Dysplasia","volume":"8","author":"Tripathy","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best Practice Management Guidelines for Fibrous Dysplasia\/McCune-Albright Syndrome: A Consensus Statement from the FD\/MAS International Consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00198-021-05895-6","article-title":"Denosumab for Craniofacial Fibrous Dysplasia: Duration of Efficacy and Post-Treatment Effects","volume":"32","author":"Raborn","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.3828","article-title":"RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease","volume":"34","author":"Palmisano","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"116301","DOI":"10.1016\/j.bone.2021.116301","article-title":"RANKL Inhibition Halts Lesion Progression and Promotes Bone Remineralization in Mice with Fibrous Dysplasia","volume":"156","author":"Liu","year":"2022","journal-title":"Bone"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-020-00166-2","article-title":"Interleukin-6-Knockdown of Chimeric Antigen Receptor-Modified T Cells Significantly Reduces IL-6 Release from Monocytes","volume":"9","author":"Kang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic Implications of IL-6 Blockade for Cytokine Storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"116343","DOI":"10.1016\/j.bone.2022.116343","article-title":"Inhibition of IL-6 in the Treatment of Fibrous Dysplasia of Bone: The Randomized Double-Blind Placebo-Controlled TOCIDYS Trial","volume":"157","author":"Chapurlat","year":"2022","journal-title":"Bone"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"101509","DOI":"10.1016\/j.smim.2021.101509","article-title":"Functions of Macrophage Colony-Stimulating Factor (CSF1) in Development, Homeostasis, and Tissue Repair","volume":"54","author":"Sehgal","year":"2021","journal-title":"Semin. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Bush, S.J., McCulloch, M.E.B., Lisowski, Z.M., Muriuki, C., Clark, E.L., Young, R., Pridans, C., Prendergast, J.G.D., Summers, K.M., and Hume, D.A. (2020). Species-Specificity of Transcriptional Regulation and the Response to Lipopolysaccharide in Mammalian Macrophages. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00661"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Keshvari, S., Caruso, M., Teakle, N., Batoon, L., Sehgal, A., Patkar, O.L., Ferrari-Cestari, M., Snell, C.E., Chen, C., and Stevenson, A. (2021). CSF1R-Dependent Macrophages Control Postnatal Somatic Growth and Organ Maturation. PLOS Genet., 17.","DOI":"10.1371\/journal.pgen.1009605"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1182\/blood-2010-02-266296","article-title":"An Antibody against the Colony-Stimulating Factor 1 Receptor Depletes the Resident Subset of Monocytes and Tissue- and Tumor-Associated Macrophages but Does Not Inhibit Inflammation","volume":"116","author":"MacDonald","year":"2010","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.2A0114-006R","article-title":"Pleiotropic Effects of Extended Blockade of CSF1R Signaling in Adult Mice","volume":"96","author":"Sauter","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","article-title":"Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain","volume":"115","author":"Mantyh","year":"2011","journal-title":"Anesthesiology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.174.1.7","article-title":"Nerve Growth Factor Induces Development of Connective Tissue-Type Mast Cells in Vitro from Murine Bone Marrow Cells","volume":"174","author":"Matsuda","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/MN:24:1-3:183","article-title":"Nerve Growth Factor","volume":"24","author":"Skaper","year":"2001","journal-title":"Mol. Neurobiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/bcp.13820","article-title":"Clinical and Translational Pharmacological Aspects of the Management of Fibrous Dysplasia of Bone","volume":"85","author":"Rotman","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2005.03.039","article-title":"Nerve Growth Factor Mediates Hyperalgesia and Cachexia in Auto-Immune Arthritis","volume":"116","author":"Shelton","year":"2005","journal-title":"Pain"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pain.2006.12.014","article-title":"Characterisation of Ultraviolet-B-Induced Inflammation as a Model of Hyperalgesia in the Rat","volume":"131","author":"Bishop","year":"2007","journal-title":"Pain"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","article-title":"Anti-NGF Therapy Profoundly Reduces Bone Cancer Pain and the Accompanying Increase in Markers of Peripheral and Central Sensitization","volume":"115","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrrheum.2016.224","article-title":"Anti-NGF Treatments for Pain\u2014Two Steps Forward, One Step Back?","volume":"13","author":"Lane","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jaci.2021.09.024","article-title":"Asivatrep, a TRPV1 Antagonist, for the Topical Treatment of Atopic Dermatitis: Phase 3, Randomized, Vehicle-Controlled Study (CAPTAIN-AD)","volume":"149","author":"Park","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.7150\/ijbs.59918","article-title":"The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cber.19300630331","article-title":"Synthese Des Capsaicins","volume":"63","author":"Darling","year":"1930","journal-title":"Berichte Dtsch. Chem. Ges. B Ser."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/106002809302700316","article-title":"Capsaicin: Identification, Nomenclature, and Pharmacotherapy","volume":"27","author":"Cordell","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP Channel Drug Discovery: From Target Validation to Clinical Studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/j.pain.0000000000002543","article-title":"Antibody-Induced Pain-like Behavior and Bone Erosion: Links to Subclinical Inflammation, Osteoclast Activity, and Acid-Sensing Ion Channel 3-Dependent Sensitization","volume":"163","author":"Jurczak","year":"2022","journal-title":"Pain"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"580936","DOI":"10.3389\/fimmu.2020.580936","article-title":"Acid-Sensing Ion Channel-1a in Articular Chondrocytes and Synovial Fibroblasts: A Novel Therapeutic Target for Rheumatoid Arthritis","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.104.078311","article-title":"Suramin Disrupts Receptor-G Protein Coupling by Blocking Association of G Protein \u03b1 and \u0392\u03b3 Subunits","volume":"313","author":"Chung","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-6147(99)01337-1","article-title":"G Protein Antagonists","volume":"20","author":"Freissmuth","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1073\/pnas.95.1.346","article-title":"Gs\u03b1-Selective G Protein Antagonists","volume":"95","author":"Hohenegger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","first-page":"415","article-title":"Inhibition of Receptor\/G Protein Coupling by Suramin Analogues","volume":"50","author":"Beindl","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00535-021-01846-4","article-title":"Mutant GNAS Limits Tumor Aggressiveness in Established Pancreatic Cancer via Antagonizing the KRAS-Pathway","volume":"57","author":"Kawabata","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Ding, H., Zhang, X., Su, Y., Jia, C., and Dai, C. (2020). GNAS Promotes Inflammation-Related Hepatocellular Carcinoma Progression by Promoting STAT3 Activation. Cell. Mol. Biol. Lett., 25.","DOI":"10.1186\/s11658-020-00204-1"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fendo.2019.00925","article-title":"Advances in Models of Fibrous Dysplasia\/McCune-Albright Syndrome","volume":"10","author":"Lung","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/sctm.18-0213","article-title":"Perils and Promises of Therapeutic Approaches for the Stem Cell Disease Fibrous Dysplasia","volume":"8","author":"Saggio","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Kantor, A., McClements, M., and MacLaren, R. (2020). CRISPR-Cas9 DNA Base-Editing and Prime-Editing. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176240"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00776-004-0809-0","article-title":"Oral Alendronate Treatment for Polyostotic Fibrous Dysplasia: A Case Report","volume":"9","author":"Kitagawa","year":"2004","journal-title":"J. Orthop. Sci."},{"key":"ref_182","first-page":"E48-50","article-title":"Alendronate Therapy in Polyostotic Fibrous Dysplasia Presenting with Pathologic Fracture","volume":"40","author":"Jayaraman","year":"2011","journal-title":"Am. J. Orthop. Belle Mead NJ"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1651-2227.2000.tb01214.x","article-title":"Pamidronate Treatment of Bone Fibrous Dysplasia in Nine Children with McCune-Albright Syndrome","volume":"89","author":"Lala","year":"2000","journal-title":"Acta Paediatr."},{"key":"ref_185","first-page":"929","article-title":"Pamidronate Treatment in Bone Fibrous Dysplasia in Children and Adolescents with McCune-Albright Syndrome","volume":"15","author":"Matarazzo","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4158\/EP-2018-0328","article-title":"Efficacy and Safety of Bisphosphonate Therapy in Mccune-Albright Syndrome\u2013Related Polyostotic Fibrous Dysplasia: A Single-Center Experience","volume":"25","author":"Wang","year":"2019","journal-title":"Endocr. Pract."},{"key":"ref_187","first-page":"247","article-title":"Effects of Zoledronic Acid Therapy in Fibrous Dysplasia of Bone: A Single-Center Experience","volume":"66","author":"Valadares","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"101058","DOI":"10.1016\/j.bonr.2021.101058","article-title":"Regression of Fibrous Dysplasia in Response to Denosumab Therapy: A Report of Two Cases","volume":"14","author":"Meier","year":"2021","journal-title":"Bone Rep."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc2214862","article-title":"Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone","volume":"388","author":"Michel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/rheumatology\/kev221","article-title":"Tocilizumab in the Treatment of a Polyostotic Variant of Fibrous Dysplasia of Bone","volume":"54","author":"Johnson","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"114884","DOI":"10.1016\/j.ejmech.2022.114884","article-title":"CSF1R Inhibitors Are Emerging Immunotherapeutic Drugs for Cancer Treatment","volume":"245","author":"Wen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_192","first-page":"1","article-title":"A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects with Cancer Pain Due to Bone Metastasis","volume":"XX","author":"Fallon","year":"2023","journal-title":"Oncologist"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/sjpain-2017-0184","article-title":"A Multiple-Dose Double-Blind Randomized Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Analgesic Efficacy of the TRPV1 Antagonist JNJ-39439335 (Mavatrep)","volume":"18","author":"Manitpisitkul","year":"2018","journal-title":"Scand. J. Pain"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1039\/C6BM00091F","article-title":"Inhibition of Fibrous Dysplasia via Blocking Gs\u03b1 with Suramin Sodium Loaded with an Alendronate-Conjugated Polymeric Drug Delivery System","volume":"4","author":"Lv","year":"2016","journal-title":"Biomater. Sci."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Watanabe, K., Nakamura, T., Onodera, S., Saito, A., Shibahara, T., and Azuma, T. (2020). A Novel GNAS-Mutated Human Induced Pluripotent Stem Cell Model for Understanding GNAS-Mutated Tumors. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med., 42.","DOI":"10.1177\/1010428320962588"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/21\/15591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:11:56Z","timestamp":1760130716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/21\/15591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":195,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["ijms242115591"],"URL":"https:\/\/doi.org\/10.3390\/ijms242115591","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}